Roberto Pinelli, MD, CEO, and founder of the Switzerland Eye Research Institute, shares how operations at the facility have adapted to the growing coronavirus pandemic spreading across the glob
Clinicians may safely use ranibizumab 0.5 mg in patients with bilateral age-related macular degeneration (AMD) as well as those with best-corrected visual acuity (BCVA) of less than 2/10, an Italian real-life study suggests.
In a story that is a tragedy in so many ways, Jeffrey Epstein was accused of being a serial pedophile, allegedly luring underage females into situations in which they engaged in sex with Epstein and his famous friends.
Paul Sidoti, MD, site chair of the Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai System Chief, offers insight on changes — both onsite and offsite — that have been implemen
A retrospective study concludes that surgical peripheral iridotomy (PI) has several advantages over laser treatment in some patients with uveitis.
This article was reviewed by Bennet J. McComish, PhD
Patrick Mooney, vice president and head of Ophthalmology Franchise (US) at Novartis, offers an update on how the company is responding to the impact of the global coronavirus epidemic and the intern
This article was reviewed by Rahul N. Khurana, MD
Carl Awh, MD, explains offers insight on the changes his practice (Tennessee Retina in Nashville, Tennessee), has implemented for the sake of staff/patients' health, as well as the safety precautio
This article was reviewed by Arthur B. Cummings, MD